The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACCELERATE DIAGNOSTICS INC | COM | 00430H102 | 1,916,016 | 89,200 | SH | SOLE | 89,200 | 0 | 0 | ||
| AEGERION PHARMACEUTICALS INC | COM | 00767E102 | 1,919,350 | 57,500 | SH | SOLE | 57,500 | 0 | 0 | ||
| AGIOS PHARMACEUTICALS INC | COM | 00847X104 | 6,963,225 | 113,500 | SH | SOLE | 113,500 | 0 | 0 | ||
| ALNYLAM PHARMACEUTICALS INC | COM | 02043Q107 | 2,272,710 | 29,100 | SH | SOLE | 29,100 | 0 | 0 | ||
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 8,100,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| BIND THERAPEUTICS INC | COM | 05548N107 | 3,865,500 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| BIOLINERX LTD | COM | 09071M106 | 754,600 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
| CATALYST PHARM PARTNERS INC | COM | 14888U101 | 3,237,000 | 975,000 | SH | SOLE | 975,000 | 0 | 0 | ||
| CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 1,024,650 | 405,000 | SH | SOLE | 405,000 | 0 | 0 | ||
| CELGENE CORP | RIGHT 12/31/2030 | 151020112 | 2,237,400 | 660,000 | SH | SOLE | 660,000 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 5,532,608 | 504,800 | SH | SOLE | 504,800 | 0 | 0 | ||
| CHIMERIX INC | COM | 16934W106 | 20,853,100 | 755,000 | SH | SOLE | 755,000 | 0 | 0 | ||
| CLOVIS ONCOLOGY INC. | COM | 189464100 | 6,210,400 | 140,000 | SH | SOLE | 140,000 | 0 | 0 | ||
| CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 2,953,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
| CODEXIS INC | COM | 192005106 | 3,937,700 | 1,690,000 | SH | SOLE | 1,690,000 | 0 | 0 | ||
| DICERNA PHARMACEUTICALS INC | COM | 253031108 | 1,712,185 | 134,500 | SH | SOLE | 134,500 | 0 | 0 | ||
| EVOKE PHARMA | COM | 30049G104 | 1,468,367 | 267,000 | SH | SOLE | 267,000 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 1,641,500 | 67,000 | SH | SOLE | 67,000 | 0 | 0 | ||
| GENMARK DIAGNOSTICS INC | COM | 372309104 | 4,933,500 | 550,000 | SH | SOLE | 550,000 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 1,640,000 | 820,000 | SH | SOLE | 820,000 | 0 | 0 | ||
| IMPRIMIS PHARMACEUTICALS INC | COM | 45323A201 | 3,728,550 | 502,500 | SH | SOLE | 502,500 | 0 | 0 | ||
| INSPIREMD INC | COM | 45779A309 | 4,594,700 | 2,088,500 | SH | SOLE | 2,088,500 | 0 | 0 | ||
| INSYS THERAPEUTICS INC NEWS | COM | 45824V209 | 4,750,550 | 122,500 | SH | SOLE | 122,500 | 0 | 0 | ||
| KIPS BAY MED INC | COM | 49726K105 | 8,510 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
| OPHTHOTECH CORP | COM | 683745103 | 1,362,550 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | ||
| PHARMACYCLICS INC | COM | 716933106 | 9,981,550 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
| PROTHENA CORP PLC | COM | G72800108 | 3,479,120 | 157,000 | SH | SOLE | 157,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 9,020,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TETRAPHASE PHARMACEUTICALS I | COM | 88165N105 | 3,385,515 | 169,700 | SH | SOLE | 169,700 | 0 | 0 | ||
| ULTRAGENYX PHARMACEUTICAL IN | COM | 90400D108 | 4,811,000 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||